发明名称 |
USE OF VEGF ANTAGONIST IN TREATING CHORIORETINAL NEOVASCULAR AND PERMEABILITY DISORDERS IN PAEDIATRIC PATIENTS |
摘要 |
The present invention relates to the use of a VEGF antagonist in the treatment of chorioretinal neovascular or permeability disorders in children. In particular, the invention provides a VEGF antagonist for use in a method for treating a child having CNV or ME, wherein said method comprises administering to the eye of a child a VEGF antagonist that either does not enter or is rapidly cleared from the systemic circulation. The VEGF antagonist may be administered intravitreally, e.g. through injection, or topically, e.g. in form of eye drops. The invention further provides the use of a VEGF antagonist in the manufacture of a medicament for treating a child having a chorioretinal neovascular or permeability disorder. |
申请公布号 |
US2016168240(A1) |
申请公布日期 |
2016.06.16 |
申请号 |
US201414903749 |
申请日期 |
2014.07.09 |
申请人 |
AKSENOV Sergey;BURIAN Gabriela |
发明人 |
BURIAN Gabriela;AKSENOV Sergey |
分类号 |
C07K16/22;A61F9/008;A61K39/395;A61N5/06;A61K9/00;A61K45/06 |
主分类号 |
C07K16/22 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating a child having a chorioretinal neovascular or permeability disorder comprising administering to an eye of said child a VEGF antagonist that either does not enter or is rapidly cleared from the child's systemic circulation. |
地址 |
Cambridge MA US |